SCHEMBL3288566

SCHEMBL3288566

CC(=CC1(C)CC1)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.36
CD81 P60033 1/20 0.33
PTGS1 P23219 1/20 0.32
AKR1C3 P42330 1/20 0.32
APLNR P35414 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1271391 0.91 PTGS1 (0.34) FFAR3CD81PTGS1AKR1C3APLNR
SCHEMBL3287496 0.91 PTGS1 (0.34) FFAR3CD81PTGS1AKR1C3APLNR
SCHEMBL5897818 0.91 PTGS1 (0.34) FFAR3CD81PTGS1AKR1C3APLNR
SCHEMBL479260 0.89 PTGS1 (0.33) FFAR3CD81PTGS1
SCHEMBL1334942 0.89 PTGS1 (0.33) FFAR3CD81PTGS1
SCHEMBL3292362 0.89 PTGS1 (0.33) FFAR3CD81PTGS1
SCHEMBL3288618 0.89 PTGS1 (0.33) FFAR3CD81PTGS1
SCHEMBL3291244 0.89 PTGS1 (0.33) FFAR3CD81PTGS1
SCHEMBL1271365 0.83 CD81 (0.31) CD81APLNR
SCHEMBL726326 0.79 CD81 (0.30) CD81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3186226-B1 OXIME SULFONATE DERIVATIVES BASF SE (DE) 2020-06-17 EP disclosed
US-20190171099-A1 POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT BASF SE (DE) 2019-06-06 US disclosed
US-10241399-B2 Polymerizable composition comprising an oxime sulfonate as thermal curing agent BASF SE (DE) 2019-03-26 US disclosed
US-10234761-B2 Oxime ester photoinitiators BASF SE (DE) 2019-03-19 US disclosed
EP-2668156-B1 POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT BASF SE (DE) 2018-10-31 EP disclosed
US-20170260132-A1 OXIME SULFONATE DERIVATIVES BASF SE (DE) 2017-09-14 US disclosed
EP-3186226-A1 OXIME SULFONATE DERIVATIVES BASF SE (DE) 2017-07-05 EP disclosed
US-20160377977-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2016-12-29 US disclosed
EP-3019473-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2016-05-18 EP disclosed
US-9310677-B2 Polymerizable composition comprising an oxime sulfonate as thermal curing agent BASF (DE) 2016-04-12 US disclosed
US-20160060214-A1 POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT BASF SE (DE) 2016-03-03 US disclosed
WO-2016030790-A1 OXIME SULFONATE DERIVATIVES BASF SE (DE) 2016-03-03 WO disclosed
WO-2015004565-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2015-01-15 WO disclosed
EP-2668156-A1 POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT BASF SE (DE) 2013-12-04 EP disclosed
US-20130308219-A1 POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT BASF SE (DE) 2013-11-21 US disclosed
WO-2012101245-A1 POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT BASF SE (DE) 2012-08-02 WO disclosed
US-7713680-B2 Radiation sensitive resin composition for forming a protective film, method of forming a protective film from the composition, liquid crystal display device and solid-state image sensing device JSR CORPORATION (JP) 2010-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10234761-B2 Oxime ester photoinitiators C9, C5, CBR3 FFAR3 1527/4885CD81 3292/4885PTGS1 1553/4885
US-20160377977-A1 OXIME ESTER PHOTOINITIATORS C5, C9, CBR3 FFAR3 1512/4885CD81 3304/4885PTGS1 1579/4885
US-10241399-B2 Polymerizable composition comprising an oxime sulfonate as thermal curing agent SULT1E1, COX6B1, SULT1A1 FFAR3 1764/4885CD81 3353/4885PTGS1 454/4885
US-20170260132-A1 OXIME SULFONATE DERIVATIVES CBR3, CBR1, C1R FFAR3 237/4885CD81 1475/4885PTGS1 1872/4885
US-20190171099-A1 POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT SULT1E1, COX6B1, SULT1A1 FFAR3 1764/4885CD81 3353/4885PTGS1 454/4885
US-20160060214-A1 POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT SULT1E1, COX6B1, SULT1A1 FFAR3 1764/4885CD81 3353/4885PTGS1 454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.